The Life Sciences Innovation Day brings together leaders from academia and industry (e.g. academic/clinical scientists, biotech & pharma, CROs, SMEs, etc.) to discuss current challenges and develop new concepts for an ecosystem for fostering open science and innovation. In this ecosystem of public-private partnerships, members from academia, industry, and society connect, share perspectives, and directly collaborate on high-impact research and development of projects with defined outcomes tangible in the public sphere.

The specialization of scientific researchers has been essential for developing expertise in many individual fields comprising the biomedical landscape, but the resulting culture of specialty silos has diminished cross-disciplinary collaborations, which are crucial for addressing complex problems that directly impact societal stakeholders. As a consequence, the recognition and trust of the public towards scientists has diminished, research funding has stagnated while pressing issues in medicine remain unresolved. The disruptive COVID-19 pandemic has reiterated the need to establish a fluent exchange between society and scientists, ascertaining the latter as allies of society's health and in turn, biomedical development.

To encourage open dialogue in Open Science, in the keynote lectures and expert panel discussion session, attendees will discuss:

• Citizen science as a way towards patient-oriented research
• Open Science as a strategic priority for Innovation in Biopharmaceutical Industry
• Science communication in the age of social media
  
  

Explore the lineup of keynote speakers and panelists on our Agenda!